These findings suggest the potential roles of SNAP25, GRIN2A, GABRG2, GABRA1, GRIA1, SLC17A6, and SYN1 as biomarkers to distinguish PDD from DLB. The gene discussed is GABRA1; the disease is Lewy body dementia.